Q1 2023 Holdings
Filed 2023-05-18 | 64 holdings | $358.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Seagen Inc(SGENUSD) | COM | 81181C104 | $40.5M | 200,200 | 11.3% |
| Amgen Inc COM(AMGN) | COM | 031162100 | $22.1M | 91,246 | 6.2% |
| Incyte Corp(INCY) | COM | 45337C102 | $20.2M | 279,000 | 5.6% |
| Harmony Biosciences Hldgs(HRMY) | COM | 413197104 | $18.6M | 570,500 | 5.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $16.7M | 593,000 | 4.7% |
| Supernus Pharms.(SUPN) | COM | 868459108 | $15.3M | 423,500 | 4.3% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $14.0M | 257,856 | 3.9% |
| Ultragenyx Pharm.(RARE) | COM | 90400D108 | $10.6M | 264,052 | 3.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $10.5M | 543,000 | 2.9% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $10.4M | 33,000 | 2.9% |
| Uniqure NV(QURE) | SHS | N90064101 | $9.6M | 478,500 | 2.7% |
| Alnylam Pharms.(ALNY) | COM | 02043Q107 | $9.3M | 46,600 | 2.6% |
| Regeneron Pharms.(REGN) | COM | 75886F107 | $9.2M | 11,200 | 2.6% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $9.1M | 244,000 | 2.5% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $7.8M | 143,500 | 2.2% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $7.7M | 1,002,257 | 2.2% |
| Chinook Therapeutics(290A) | COM | 16961L106 | $7.4M | 319,989 | 2.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $6.4M | 28,500 | 1.8% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $6.3M | 573,530 | 1.8% |
| Illumina Inc(ILMN) | COM | 452327109 | $6.2M | 26,500 | 1.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $5.9M | 21,400 | 1.7% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $5.9M | 183,000 | 1.6% |
| Biomarin Pharm.(BMRN) | COM | 09061G101 | $5.7M | 58,656 | 1.6% |
| Dyne Therapeutics(DYN) | COM | 26818M108 | $5.0M | 433,751 | 1.4% |
| Beigene ADR(ONC) | Sponsored ADR | 07725L102 | $4.9M | 22,700 | 1.4% |
| Krystal Biotech(KRYS) | COM | 501147102 | $4.9M | 61,000 | 1.4% |
| Gilead Sciences(GILD) | COM | 375558103 | $4.8M | 57,584 | 1.3% |
| Astrazeneca PLC Sponsored(AZN) | SPONSORED ADR | 046353108 | $4.5M | 65,000 | 1.3% |
| PTC Therapeutics(PTCT) | COM | 69366J200 | $4.5M | 93,000 | 1.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $4.3M | 1,426,000 | 1.2% |
| Acadia Pharmaceuticals in(ACAD) | COM | 004225108 | $4.1M | 216,000 | 1.1% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $3.3M | 88,000 | 0.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $3.2M | 141,019 | 0.9% |
| Ascendis Pharma ADR(ASND) | Sponsored ADR | 04351P101 | $3.2M | 29,400 | 0.9% |
| Zai Lab Ltd ADR (V1 Ord)(ZLAB) | ADR | 98887Q104 | $2.6M | 78,958 | 0.7% |
| Jazz Pharms.(JAZZ) | SHS USD | G50871105 | $2.5M | 17,200 | 0.7% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $2.4M | 457,892 | 0.7% |
| Apellis Pharms.(APLS) | COM | 03753U106 | $2.1M | 31,700 | 0.6% |
| Karuna Therapeutics Inc | COM | 48576A100 | $2.0M | 11,000 | 0.6% |
| Denali Therapeutics(DNLI) | COM | 24823R105 | $2.0M | 86,575 | 0.6% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $1.9M | 32,000 | 0.5% |
| Legend Biotech(LEGN) | SPONSORED ADS | 52490G102 | $1.8M | 38,000 | 0.5% |
| Guardant Health(GH) | COM | 40131M109 | $1.7M | 74,500 | 0.5% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $1.7M | 45,500 | 0.5% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $1.6M | 67,500 | 0.5% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.5M | 34,200 | 0.4% |
| Ionis Pharms.(IONS) | COM | 462222100 | $1.5M | 43,000 | 0.4% |
| Rocket Pharms.(RCKT) | COM | 77313F106 | $1.1M | 63,000 | 0.3% |
| I-Mab(NBP) | SPONSORED ADS | 44975P103 | $1.1M | 310,499 | 0.3% |
| Novavax Inc(NVAX) | COM | 670002401 | $924.9K | 132,500 | 0.3% |